Background Up to the end of January, 2022, South Africa has had four recognisable COVID-19
pandemic waves, each predominantly dominated by one variant of concern: the …

OBJECTIVES The objective was to compare COVID‐19 outcomes in the Omicron‐driven fourth
wave with prior waves in the Western Cape, assess the contribution of undiagnosed prior …

Objectives We aimed to compare the clinical severity of Omicron BA.4/BA.5 infection with BA.1
and earlier variant infections among laboratory-confirmed SARS-CoV-2 cases in the …

Background We aimed to assess the effectiveness of a single dose of the Ad26.COV2.S
vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the …

Background In this study, we compared admission incidence risk and the risk of mortality in
the Omicron BA.4/BA.5 wave to previous waves. Methods Data from South Africa's SARS-…

Background At present, it is unclear whether the extent of reduced risk of severe disease
seen with SARS-Cov-2 Omicron variant infection is caused by a decrease in variant virulence …

Background In 2021, the HIV prevalence among South African adults was 18% and more
than 2 million people had uncontrolled HIV and, therefore, had increased risk of poor …

… Subventions on petroleum products arose in detriment to the company performance. 17.
The government authorized the Central Bank to put its hands over PdVSA’s investment funds …

Background: The Sisonke phase 3B open-label implementation study vaccinated health
care workers (HCWs) with the single dose Ad26. COV2. S vaccine during two phases of the …

… The firm produced petroleum products until the Second World War as it was then taken over
… It committed to fund research with $40 million and ensured that Petro-Canada would be a …